Effect of various ACTH preparations and of metyrapone on the secretion of growth hormone in normal subjects and in hypopituitary patients.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D000328:Adult; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism; D002417:Cattle; D002648:Child; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007018:Hypopituitarism / Q000097:blood*; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D008797:Metyrapone / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D013552:Swine; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D001786:Blood Glucose; D007328:Insulin; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D001120:Arginine; D005947:Glucose; D006854:Hydrocortisone; D004837:Epinephrine; D008797:Metyrapone